• Je něco špatně v tomto záznamu ?

Intersexual differences in inhibitory influence of trans-resveratrol on activity of cytochrome P450 2D2 in rats

O. Zendulka, J. Totusek, A. Sulcova

. 2009 ; 30 Suppl 1 () : 88-91.

Jazyk angličtina Země Švédsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12025390

OBJECTIVES: Differences in the metabolism between males and females have been seen over time. Hormonal regulation of cytochrome P450 activity is understood to be involved. Trans-resveratrol (RES) is an estrogenically active plant polyphenol with many protective biological activities including neuroprotection. The present report studied the influence of sex and RES on variances in rat's cytochrome P450 2D2 hepatic metabolic activity. METHODS AND DESIGN: Isolated perfused rat liver was used for determination of cytochrome P450 2D2 activity. Wistar albino rats of both sexes were treated with RES at the dose of 5 mg/kg/day for 10 days prior to liver isolation. Levels of marker substance dextromethorphan (DEM) and its 2D2 specific metabolite dextrorphan (DEX) were measured during perfusion. The metabolic ratios (DEM/DEX) and the levels of DEM and DEX in perfusate were compared. RESULTS: In the controls, the activity of CYP2D2 was found to be higher in male rats compared to females. RES produced inhibition of CYP2D2, expressed by significant changes of both DEM and DEX levels in males and significant increase of only DEM levels in females. There were no gender changes in DEX levels in RES treated animals whilst DEM levels were significantly increased during the whole perfusion in females. CONCLUSION: The results confirmed gender differences in the metabolic activity of CYP450 2D2 with a higher rate in male rats. RES acted as an inhibitor, however again with greater impact in males than in females. This metabolic divergence could be a cause for different sensitivity or even toxicity of drugs metabolized by the CYP450 2D2.

000      
00000naa a2200000 a 4500
001      
bmc12025390
003      
CZ-PrNML
005      
20130128192726.0
007      
ta
008      
120816s2009 sw f 000 0#eng||
009      
AR
035    __
$a (PubMed)20027150
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Zendulka, Ondřej. $7 xx0234689 $u Department of Pharmacology, Masaryk University, Brno, Czech Republic. zendulka@med.muni.cz
245    10
$a Intersexual differences in inhibitory influence of trans-resveratrol on activity of cytochrome P450 2D2 in rats / $c O. Zendulka, J. Totusek, A. Sulcova
520    9_
$a OBJECTIVES: Differences in the metabolism between males and females have been seen over time. Hormonal regulation of cytochrome P450 activity is understood to be involved. Trans-resveratrol (RES) is an estrogenically active plant polyphenol with many protective biological activities including neuroprotection. The present report studied the influence of sex and RES on variances in rat's cytochrome P450 2D2 hepatic metabolic activity. METHODS AND DESIGN: Isolated perfused rat liver was used for determination of cytochrome P450 2D2 activity. Wistar albino rats of both sexes were treated with RES at the dose of 5 mg/kg/day for 10 days prior to liver isolation. Levels of marker substance dextromethorphan (DEM) and its 2D2 specific metabolite dextrorphan (DEX) were measured during perfusion. The metabolic ratios (DEM/DEX) and the levels of DEM and DEX in perfusate were compared. RESULTS: In the controls, the activity of CYP2D2 was found to be higher in male rats compared to females. RES produced inhibition of CYP2D2, expressed by significant changes of both DEM and DEX levels in males and significant increase of only DEM levels in females. There were no gender changes in DEX levels in RES treated animals whilst DEM levels were significantly increased during the whole perfusion in females. CONCLUSION: The results confirmed gender differences in the metabolic activity of CYP450 2D2 with a higher rate in male rats. RES acted as an inhibitor, however again with greater impact in males than in females. This metabolic divergence could be a cause for different sensitivity or even toxicity of drugs metabolized by the CYP450 2D2.
650    _2
$a zvířata $7 D000818
650    _2
$a aromatické hydroxylasy $x antagonisté a inhibitory $x metabolismus $7 D001189
650    _2
$a systém (enzymů) cytochromů P-450 $x metabolismus $7 D003577
650    _2
$a dextromethorfan $x chemie $x metabolismus $7 D003915
650    _2
$a dextrorfan $x chemie $x metabolismus $7 D003917
650    _2
$a inhibitory enzymů $x farmakologie $7 D004791
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a játra $x účinky léků $x metabolismus $7 D008099
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a pohlavní dimorfismus $7 D012727
650    _2
$a stilbeny $x farmakologie $7 D013267
650    _2
$a inhibitory cytochromu P450 $7 D065607
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Totušek, Jiří, $d 1945- $7 xx0055061
700    1_
$a Šulcová, Alexandra, $d 1945- $7 jn20000402920
773    0_
$w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 30 Suppl 1(2009), s. 88-91
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20027150 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120816 $b ABA008
991    __
$a 20130128192908 $b ABA008
999    __
$a ok $b bmc $g 947432 $s 782736
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2009 $b 30 Suppl 1 $d 88-91 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
LZP    __
$a Pubmed-20120816/10/02

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...